Scarica l'app Stockscreener
3.76
3.16%
0.12
Dopo l'orario di chiusura:
3.76
Precedente Chiudi:
$3.64
Aprire:
$3.66
Volume 24 ore:
482.48K
Relative Volume:
0.60
Capitalizzazione di mercato:
$167.54M
Reddito:
-
Utile/perdita netta:
$-147.71M
Rapporto P/E:
-1.0486
EPS:
-3.5857
Flusso di cassa netto:
$-127.89M
1 W Prestazione:
-0.40%
1M Prestazione:
-72.49%
6M Prestazione:
-77.87%
1 anno Prestazione:
-85.01%
Intervallo 1D:
$3.59
$3.78
Intervallo di 1 settimana:
$3.59
$4.06
Portata 52W:
$3.00
$33.92
Cargo Therapeutics Inc Stock (CRGX) Company Profile
Nome
Cargo Therapeutics Inc
Settore
Industria
Telefono
650-499-8950
Indirizzo
835 INDUSTRIAL ROAD, SUITE 400, SAN CARLOS
Confronta CRGX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CRGX
Cargo Therapeutics Inc
|
3.76 | 167.54M | 0 | -147.71M | -127.89M | -3.5857 |
|
VRTX
Vertex Pharmaceuticals Inc
|
479.79 | 121.85B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
698.74 | 76.83B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
624.67 | 37.96B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
246.75 | 30.69B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beone Medicines Ltd Adr
|
271.80 | 29.71B | 3.32B | -860.46M | -1.04B | -8.32 |
Cargo Therapeutics Inc Stock (CRGX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-01-30 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| 2025-01-30 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2025-01-30 | Downgrade | JP Morgan | Overweight → Underweight |
| 2025-01-30 | Downgrade | Jefferies | Buy → Hold |
| 2025-01-30 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2025-01-30 | Downgrade | Truist | Buy → Hold |
| 2025-01-30 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2024-11-26 | Iniziato | William Blair | Outperform |
| 2024-07-22 | Iniziato | H.C. Wainwright | Buy |
| 2024-07-08 | Iniziato | Chardan Capital Markets | Buy |
| 2024-06-27 | Iniziato | Piper Sandler | Overweight |
| 2023-12-05 | Iniziato | JP Morgan | Overweight |
| 2023-12-05 | Iniziato | Jefferies | Buy |
| 2023-12-05 | Iniziato | TD Cowen | Outperform |
| 2023-12-05 | Iniziato | Truist | Buy |
Mostra tutto
Cargo Therapeutics Inc Borsa (CRGX) Ultime notizie
CARGO Therapeutics Discloses Strategic Corporate Presentation via SEC Filing - Defense World
Alector Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - The Manila Times
Layoff Tracker: Lava, Ryvu Cutting 30% of Their Workforces - BioSpace
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of CARGO Therapeutics, IncCRGX - PR Newswire
IPOs Numbers Rise In 2024, But Dwindling Returns Could Diminish Potential In 2025 - Insights
CARGO Therapeutics Highlights Progress in CAR T Therapy - TipRanks
Levi & Korsinsky Reminds CARGO Therapeutics, Inc. Investors of the Ongoing Investigation into Potential Violations of Securities LawsCRGX - ACCESS Newswire
After Plunging -69.58% in 4 Weeks, Here's Why the Trend Might Reverse for CARGO Therapeutics, Inc. (CRGX) - Yahoo Finance
You might want to take a look at CARGO Therapeutics Inc (CRGX) now - SETE News
CARGO Therapeutics, Inc. (NASDAQ:CRGX) Receives Consensus Recommendation of "Reduce" from Brokerages - MarketBeat
CARGO Therapeutics, Inc. (NASDAQ:CRGX) Receives Consensus Recommendation of “Reduce” from Brokerages - Defense World
CARGO Therapeutics, Inc. (CRGX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - Markets Insider
ATTENTION CARGO Therapeutics, Inc. Investors: You May Have Been Affected by FraudContact Levi & Korsinsky to Discuss Your Rights - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Encourages CARGO Therapeutics, Inc. (CRGX) Shareholders to Inquire about Securities Investigation - Markets Insider
Here's Why CARGO Therapeutics, Inc. (CRGX) Could be Great Choice for a Bottom Fisher - Yahoo Finance
41,124 Shares in CARGO Therapeutics, Inc. (NASDAQ:CRGX) Bought by abrdn plc - Defense World
Finance Watch: Third Harmonic, Q32 Bio Cut Jobs To Focus On Lead Assets - News & Insights
Bronstein, Gewirtz & Grossman, LLC Is Investigating CARGO Therapeutics, Inc. (CRGX) And Encourages Shareholders to Connect - Markets Insider
Full List of Companies in California Laying Off Employees This Year - Newsweek
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against CARGO Therapeutics, Inc. (CRGX) And Encourages Shareholders to Reach Out - Markets Insider
Quarterly Snapshot: Quick and Current Ratios for CARGO Therapeutics Inc (CRGX) - The Dwinnex
Bronstein, Gewirtz & Grossman, LLC Encourages CARGO Therapeutics, Inc. (CRGX) Stockholders to Inquire about Securities Investigation - Markets Insider
Stock Market Movers: FOXX and AMOD Surge While CRGX and CRKN Face Sharp Declines - HPBL
Evaluating the Ups and Downs of CARGO Therapeutics Inc’s (CRGX) Stock - The News Heater
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against CARGO Therapeutics, Inc. (CRGX) and Encourages Investors to Learn More About the Investigation - Markets Insider
Research Analysts Set Expectations for CRGX Q1 Earnings - MarketBeat
CRGX Investors Have Opportunity to Join CARGO Therapeutics, Inc. - GuruFocus.com
CRGX Investors Have Opportunity to Join CARGO Therapeutics, Inc. Securities Fraud Investigation with the Schall Law Firm - Longview News-Journal
HC Wainwright Issues Positive Outlook for CRGX Earnings - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Is Investigating CARGO Therapeutics, Inc. (CRGX) And Encourages Investors to Connect - Markets Insider
CARGO Therapeutics (NASDAQ:CRGX) Hits New 52-Week LowTime to Sell? - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against CARGO Therapeutics, Inc. (CRGX) and Encourages Stockholders to Learn More About the Investigation - Markets Insider
Did CARGO Therapeutics Inc (CRGX) perform well in the last session? - US Post News
Closing Bell Recap: CARGO Therapeutics Inc (CRGX) Ends at 3.65, Reflecting a 1.39 Upturn - The Dwinnex
CARGO Therapeutics (NASDAQ:CRGX) Stock Rating Lowered by Truist Financial - MarketBeat
CARGO Therapeutics (NASDAQ:CRGX) Cut to Neutral at Chardan Capital - MarketBeat
CARGO Therapeutics (NASDAQ:CRGX) Rating Lowered to Neutral at HC Wainwright - MarketBeat
CARGO Therapeutics (NASDAQ:CRGX) Stock Rating Lowered by William Blair - MarketBeat
CARGO Therapeutics (NASDAQ:CRGX) Rating Lowered to Hold at Jefferies Financial Group - MarketBeat
CARGO Therapeutics (NASDAQ:CRGX) Downgraded to "Neutral" Rating by Piper Sandler - MarketBeat
CARGO Therapeutics (NASDAQ:CRGX) Lowered to "Underweight" Rating by JPMorgan Chase & Co. - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Encourages CARGO Therapeutics, Inc. (CRGX) Investors to Inquire about Securities Investigation - Markets Insider
CARGO Therapeutics, Inc. (CRGX) Upgraded to Buy: What Does It Mean for the Stock? - MSN
CARGO Therapeutics stock hits 52-week low at $3.12 - MSN
Cargo Therapeutics stock tumbles after trial setback - MSN
HC Wainwright Expects Higher Earnings for CARGO Therapeutics - Defense World
William Blair Has Optimistic Outlook of CRGX Q1 Earnings - Defense World
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against CARGO Therapeutics, Inc. (CRGX) And Encourages Investors to Reach Out - Markets Insider
CARGO Therapeutics (NASDAQ:CRGX) Sets New 1-Year Low – Here’s What Happened - Defense World
Stock summary: CARGO Therapeutics reflected weekly fall of 73.11% - Business Upturn
Piper Sandler Downgrades CARGO Therapeutics (NASDAQ:CRGX) to Neutral - Defense World
Cargo Therapeutics Inc Azioni (CRGX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Cargo Therapeutics Inc Azioni (CRGX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Chapman Gina | President & CEO |
Sep 19 '24 |
Option Exercise |
5.03 |
2,975 |
14,964 |
106,880 |
| Chapman Gina | President & CEO |
Sep 18 '24 |
Sale |
25.09 |
7,166 |
179,775 |
103,905 |
| Chapman Gina | President & CEO |
Sep 19 '24 |
Sale |
25.03 |
2,975 |
74,457 |
103,905 |
| Radhakrishnan Anup | Chief Financial Officer |
Sep 18 '24 |
Option Exercise |
5.03 |
1,600 |
8,048 |
8,046 |
| Radhakrishnan Anup | Chief Financial Officer |
Sep 18 '24 |
Sale |
25.28 |
1,600 |
40,452 |
6,446 |
2.95%
0.31%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):